| 000 | 01680 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515105209.0 | ||
| 264 | 0 | _c20080403 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1421-9913 | ||
| 024 | 7 |
_a10.1159/000114036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHengstman, G J D | |
| 245 | 0 | 0 |
_aOpen-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate. _h[electronic resource] |
| 260 |
_bEuropean neurology _c2008 |
||
| 300 |
_a159-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aDermatomyositis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolymyositis _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
| 700 | 1 | _aDe Bleecker, J L | |
| 700 | 1 | _aFeist, E | |
| 700 | 1 | _aVissing, J | |
| 700 | 1 | _aDenton, C P | |
| 700 | 1 | _aManoussakis, M N | |
| 700 | 1 | _aSlott Jensen, H | |
| 700 | 1 | _avan Engelen, B G M | |
| 700 | 1 | _avan den Hoogen, F H J | |
| 773 | 0 |
_tEuropean neurology _gvol. 59 _gno. 3-4 _gp. 159-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000114036 _zAvailable from publisher's website |
| 999 |
_c17737699 _d17737699 |
||